Cowen And Company »

Alternus shares owned by Cowen And Company

Quarter-by-quarter ownership of Alternus (ALCE) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Alternus

Tip: Access up to 7 years of quarterly data

All positions including Alternus held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alternus by Cowen And Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 75k 0.43
2023-12-31 $45k 30k 1.50

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Coinbase Global Com Cl A (COIN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Avidity Biosciences Ord (RNA)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ptc Therapeutics I (PTCT)
Tarsus Pharmaceuticals (TARS)
Quanta Services (PWR)
Establishment Labs Holdings Ord (ESTA)
Stoke Therapeutics (STOK)
Protagonist Therapeutics (PTGX)
Apple (AAPL)
Fulcrum Therapeutics (FULC)
Sumitomo Mitsui Finl Group I Sponsored Adr (SMFG)

View all positions for Cowen And Company

Top funds holding Alternus

Saba Capital Management
Cowen And Company
Polar Securities
Parkwood
Millennium Management
Kim
CNH Partners
Walleye Trading Advisors
Jpmorgan Chase & Co
Walleye Trading
Marshall Wace
D. E. Shaw & Co
Virtu Financial
Whitebox Advisors
Elequin Capital

View all funds holding Alternus